https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2003-02-01 / Clin. Breast Cancer 2003 Feb;3 Suppl 4:S158-63
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2003-02-01 / Clin. Breast Cancer 2003 Feb;3 Suppl 4:S158-632003-02-01 00:00:002019-02-15 08:50:30Fusions of breast cancer and dendritic cells as a novel cancer vaccine
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2003-02-01 / Expert Rev Anticancer Ther 2003 Feb;3(1):1-3
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2003-02-01 / Expert Rev Anticancer Ther 2003 Feb;3(1):1-32003-02-01 00:00:002019-02-15 08:44:50Dendritic cell therapy of cancer: can it fulfill its promise?
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2003-02-01 / Clin Breast Cancer 2003 Feb;3 Suppl 4:S164-72
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2003-02-01 / Clin Breast Cancer 2003 Feb;3 Suppl 4:S164-722003-02-01 00:00:002003-02-01 00:00:00HER2 dendritic cell vaccines
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2003-01-01 / Cancer Invest. 2003;21(6):873-86
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2003-01-01 / Cancer Invest. 2003;21(6):873-862003-01-01 00:00:002019-02-15 08:44:48The first 1000 dendritic cell vaccinees
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2003-01-01 / Int. J. Cancer 2003 Jan;103(1):73-83
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2003-01-01 / Int. J. Cancer 2003 Jan;103(1):73-832003-01-01 00:00:002020-06-23 09:43:21Cognate interactions between memory T cells and tumor antigen-presenting dendritic cells from bone marrow of breast cancer patients: bidirectional cell stimulation, survival and antitumor activity in vivo
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2002-12-01 / Cancer Biother. Radiopharm. 2002 Dec;17(6):601-19
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2002-12-01 / Cancer Biother. Radiopharm. 2002 Dec;17(6):601-192002-12-01 00:00:002019-02-15 08:44:50Advances in dendritic cell-based vaccine of cancer
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2002-11-01 / Int J Hyperthermia 2002 Nov-Dec;18(6):506-20
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2002-11-01 / Int J Hyperthermia 2002 Nov-Dec;18(6):506-202002-11-01 00:00:002019-02-15 08:48:26Cancer immunotherapy: stress proteins and hyperthermia
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2002-10-29 / Cancer Immunol. Immunother. 2002 Dec;51(11-12):663-8
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2002-10-29 / Cancer Immunol. Immunother. 2002 Dec;51(11-12):663-82002-10-29 00:00:002019-02-15 08:53:33Calcitonin-specific antitumor immunity in medullary thyroid carcinoma following dendritic cell vaccination
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2002-09-01 / Haematologica 2002 Sep;87(9):989-1001
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2002-09-01 / Haematologica 2002 Sep;87(9):989-10012002-09-01 00:00:002019-02-15 08:51:09Idiotypic vaccination for B-cell malignancies as a model for therapeutic cancer vaccines: from prototype protein to second generation vaccines
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2002-09-01 / Blood 2002 Sep;100(5):1734-41
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2002-09-01 / Blood 2002 Sep;100(5):1734-412002-09-01 00:00:002019-02-15 08:44:52Developmental kinetics and lifespan of dendritic cells in mouse lymphoid organs
